The OCTDI under the Office of the Vice President for Health Sciences serves as a hub interconnecting interdisciplinary clinical trial research collaborations among UB investigators and our regional ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Educational ...

We are witnessing an increasing demand for rapid, rigorous, and generalizable evidence to inform health care systems’ learning and address inefficiencies in the current clinical trials landscape.

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

Study participants for this study were recruited at two National Cancer Institute–designated comprehensive cancer centers (CCCs) from April 8, 2019, to September 19, 2019. Eligible participants were ...

Artificial Intelligence (AI) can augment productivity in clinical trial delivery and more, says Piotr Maslak, Director of Operational Data Intelligence at AstraZeneca. Maslak was speaking on the first ...

Over the past several years, pharmaceutical companies have been steadily integrating artificial intelligence (AI) into many aspects of clinical development. Today, AI’s impact is being felt from the ...